Month: February 2024

Agora, Inc. Reports Fourth Quarter and Fiscal Year 2023 Financial Results

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Agora, Inc. (NASDAQ: API) (the “Company”), a pioneer and leader in real-time engagement technology, today announced its unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2023. “We ended 2023 with strong financial results in the fourth quarter, as we delivered sequential quarterly revenue growth and a non-GAAP net income of $1.4 million, achieving quarterly profitability on the non-GAAP basis for the first time in more than three years. This demonstrates the resilience of our business amid a very challenging operating environment, as well as our continued discipline and efforts in optimizing our cost structure,” said Tony Zhao, founder, chairman and CEO of Agora, Inc. “During the past two years, we returned approximately $104.3 million...

Timbercreek Financial Announces 2023 Fourth Quarter Results and Special Dividend

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) — Timbercreek Financial (TSX: TF) (the “Company”) announced today its financial results for the three months and year ended December 31, 2023 (“Q4 2023”). Full-Year 2023 Highlights1Record net investment income of $124.2 million versus $109.8 million in 2022.Net income and comprehensive income of $66.4 million, up from $55.9 million last year. Basic and diluted earnings per share for 2023 were $0.80, and $0.78 (2022 – $0.67 and $0.67).Distributable income of $70.4 million, or $0.84 per share (2022 – $66.2 million, $0.79 per share) representing a payout ratio of 81.9% on distributable income.Shareholders’ equity of $701.1 million at year end (book value per share of $8.45).Subsequent to quarter end:The Company is declaring a $0.0575 per share special dividend to shareholders...

Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024 Phase 2 FIREFLY-1 tovorafenib registrational data published in Nature Medicine Ended 2023 with $366.3 million in cash, cash equivalents and short-term investments providing runway into 2026 BRISBANE, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced its fourth quarter and full year 2023 financial results and highlighted recent corporate achievements. “We have a monumental year ahead of us at Day One with the upcoming PDUFA date for tovorafenib,” said Jeremy Bender, Ph.D., chief executive...

Dorman Products, Inc. Reports Fourth Quarter and Full Year 2023 Results; Issues 2024 Guidance

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

Highlights (All comparisons are to the prior year period unless otherwise noted):Net sales of $494.3 million for the quarter, down 1% reflecting the impact of an extra week in the prior year period, up 3% excluding this impact Record diluted earnings per share (“EPS”) of $1.60 for the quarter, up 182% compared to $0.57 Record adjusted diluted EPS* of $1.57 for the quarter, up 55% compared to $1.01 Generated $60 million of cash from operating activities; repaid $30 million of debt and repurchased $15 million of its shares during the quarter For full year 2023, achieved diluted EPS of $4.10, adjusted diluted EPS* of $4.54 and record net sales of $1.93 billionCOLMAR, Pa., Feb. 26, 2024 (GLOBE NEWSWIRE) — Dorman Products, Inc. (the “Company” or “Dorman”) (NASDAQ: DORM), a leading supplier in the motor vehicle aftermarket industry,...

Eos Energy Enterprises Announces Dates for Fourth Quarter & Full Year 2023 Financial Results

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

EDISON, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), a leading provider of safe, scalable, efficient, and sustainable zinc-based long duration energy storage systems, today announced it will release its fourth quarter and full year 2023 financial results after the U.S. market closes on March 4, 2024. A conference call to discuss its results will take place the following morning on March 5 at 8:30 a.m. Eastern Time. Registration Information A live webcast of the earnings call will be available on the “Investor Relations” page of the Company’s website at https://investors.eose.com. To access the call by phone, please register in advance using this link (registration link), and you will be provided with dial in details via email upon registration. To avoid...

Premier Health Reports 2024 First Quarter Results

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

MONTRÉAL, Feb. 26, 2024 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly Consolidated Financial Statements and MD&A for its first quarter ended on December 31st, 2023.Highlights (in thousands of Canadian dollars) Dec. 31, 2023(3 months) Dec. 31, 2022(3 months)Revenues 36,973 21,576 Gross margin 7,657 5,064 Gross margin as a % of revenues 20.7 % 23.5 %Adjusted EBITDA (1) 2,622 1,504 Net Loss (231 ) (376 )(1) See the Corporation’s MD&A for details on this non-GAAP measure.SummaryAcquisition of Solutions Staffing of British Columbia (“SSI”) and $50 million refinancing completed on November 9th, 2023. Gross margin for the quarter at 20.7% in-line with our revised...

Postal Realty Trust, Inc. Reports Fourth Quarter and Year End 2023 Results

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

– Acquired 75 USPS Properties for $20.7 Million in Fourth Quarter 2023 –– Net Income Attributable to Common Shareholders of $0.12 and Adjusted Funds from Operations of $1.07 Per Diluted Share for the Year Ended 2023 –– Raised Dividend Per Share for Fifth Consecutive Year –– Collected 100% of Contractual Rents – CEDARHURST, N.Y., Feb. 26, 2024 (GLOBE NEWSWIRE) — Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 1,900 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, today announced results for the quarter and year ended December 31, 2023. Highlights for the Quarter Ended December 31, 2023Acquired 75 USPS properties...

Telix Expands U.S. Development and Manufacturing Infrastructure with Acquisition of IsoTherapeutics

Written by Customer Service on February 26, 2024. Posted in Mergers And Acquisitions.

MELBOURNE, Australia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in Angleton, Texas. Founded in 2005, IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract manufacturing services to many companies in the radiopharmaceutical industry, including Telix. In line with Telix’s continued investment in the vertical integration of supply chain, manufacturing and development capabilities, the acquisition is expected to further enhance Telix’s in-house drug development capabilities. A key driver for the acquisition is to enable Telix...

CrossAmerica Partners LP Reports Fourth Quarter and Full Year 2023 Results

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

Allentown, PA, Feb. 26, 2024 (GLOBE NEWSWIRE) — CrossAmerica Partners LP Reports Fourth Quarter and Full Year 2023 ResultsReported Fourth Quarter 2023 Net Income of $16.7 million, Adjusted EBITDA of $47.6 million and Distributable Cash Flow of $35.8 million compared to Fourth Quarter 2022 Net Income of $17.1 million, Adjusted EBITDA of $44.3 million and Distributable Cash Flow of $33.3 million Generated Full Year 2023 Net Income of $42.6 million, Adjusted EBITDA of $165.8 million and Distributable Cash Flow of $116.7 million compared to Full Year 2022 Net Income of $63.7 million, Adjusted EBITDA of $179.8 million and Distributable Cash Flow of $140.9 million Reported Fourth Quarter 2023 Gross Profit for the Wholesale Segment of $33.0 million compared to $32.8 million of Gross Profit for the Fourth Quarter 2022 and Fourth Quarter...

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

Written by Customer Service on February 26, 2024. Posted in Earnings Releases And Operating Results.

SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights (all comparisons are to the prior year period)Worldwide revenue of $38.9 million, representing an increase of ~22% U.S. revenue of $36.7 million, representing an increase of ~22% Gross Margin of ~74%, reflecting a ~4 percentage point reduction from excess inventory reserve Over 1,130 active physicians, representing an increase of ~22% Cash and equivalents of ~$166 million, representing net cash usage of ~$0.8 millionFiscal Year 2023 Highlights (all comparisons are to the prior year period)Worldwide revenue of $138.9 million,...

Month: February 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals